It is believed the lenacapavir shot could end HIV/Aids in the country within 14 to 18 years if enough people were to take it.
Through a US$ 29 million grant, South Africa will receive enough medicine to provide HIV prevention to 450 000 people at high ...
South Africa has become the first African country, and our medicines regulator the third worldwide, to register the ...
South Africa's health minister has called lenacapavir, the first twice-yearly HIV prevention jab, a "groundbreaking" tool against the disease.
The South African Health Products Regulatory Authority (SAHPRA) has announced the registration of lenacapavir, making South Africa the first country on the continent to approve the groundbreaking ...
UMZIMKHULU, South Africa — At a rural village in South Africa's KwaZulu-Natal province, unemployed 19-year-old Nozuko Majola is trying to figure out if she has enough money for the one-hour ride to ...
A new way to prevent HIV infection is generating great buzz -- and more than a bit of controversy -- at this week’s AIDS 2024 Conference in Munich. The treatment consists of a twice-yearly injection ...
Thousands of teachers in southern Africa are dying of Aids-related illnesses as relief agencies battle to get support from the international community to help combat "the greatest humanitarian crisis ...